In vivo single-photon emission computed tomography imaging of apoptosis in Crohn's disease and anti-tumour necrosis factor therapy.
作者信息
Watson Alastair J M
机构信息
School of Clinical Sciences, The Henry Wellcome Laboratory, Nuffield Building, University of Liverpool, Crown Street, Liverpool L69 3GE, UK.
出版信息
Gut. 2007 Apr;56(4):461-3. doi: 10.1136/gut.2006.111286.
Abstract
摘要
相似文献
1
In vivo single-photon emission computed tomography imaging of apoptosis in Crohn's disease and anti-tumour necrosis factor therapy.
Gut. 2007 Apr;56(4):461-3. doi: 10.1136/gut.2006.111286.
2
Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
Gut. 2007 Apr;56(4):509-17. doi: 10.1136/gut.2006.105379. Epub 2006 Nov 2.
3
Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
Inflamm Bowel Dis. 2000 May;6(2):137-9. doi: 10.1097/00054725-200005000-00011.
4
Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):E54-5. doi: 10.1002/ibd.22998.
5
Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?
Gut. 2002 Sep;51(3):362-3. doi: 10.1136/gut.51.3.362.
6
[Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
Z Gastroenterol. 2003 Jan;41(1):11-7. doi: 10.1055/s-2003-36677.
7
[Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
Z Gastroenterol. 2005 Jul;43(7):689-90. doi: 10.1055/s-2005-858274.
8
Infliximab (Remicade), a new biological treatment for Crohn's disease.
Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):519-20.
9
[Management and treatment of Crohn's disease. 2. Anti-cytokine therapy].
Nihon Naika Gakkai Zasshi. 2009 Jan 10;98(1):88-93. doi: 10.2169/naika.98.88.
10
Pericarditis as a complication of infliximab therapy in Crohn's disease.
Inflamm Bowel Dis. 2008 Mar;14(3):428-9. doi: 10.1002/ibd.20270.
引用本文的文献
1
Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.
RMD Open. 2018 Apr 9;4(1):e000667. doi: 10.1136/rmdopen-2018-000667. eCollection 2018.
本文引用的文献
1
Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
Gut. 2007 Apr;56(4):509-17. doi: 10.1136/gut.2006.105379. Epub 2006 Nov 2.
2
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
Gut. 2007 Feb;56(2):293-303. doi: 10.1136/gut.2005.090464. Epub 2006 Sep 6.
3
Tumor necrosis factor inhibitors for rheumatoid arthritis.
N Engl J Med. 2006 Aug 17;355(7):704-12. doi: 10.1056/NEJMct055183.
4
Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
Gastroenterology. 2006 Jun;130(7):1962-74. doi: 10.1053/j.gastro.2006.03.022.
5
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Gastroenterology. 2006 Feb;130(2):323-33; quiz 591. doi: 10.1053/j.gastro.2005.11.030.
6
Resolution of inflammation: the beginning programs the end.
Nat Immunol. 2005 Dec;6(12):1191-7. doi: 10.1038/ni1276.
7
The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum.
Hepatology. 2005 Jul;42(1):113-20. doi: 10.1002/hep.20747.
8
Imaging apoptosis in vivo using 124I-annexin V and PET.
Nucl Med Biol. 2005 May;32(4):395-402. doi: 10.1016/j.nucmedbio.2004.12.008.
9
MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET.
Nucl Med Biol. 2005 Apr;32(3):241-52. doi: 10.1016/j.nucmedbio.2004.11.006.
10
Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept.
Aliment Pharmacol Ther. 2005 Feb 1;21(3):251-8. doi: 10.1111/j.1365-2036.2005.02309.x.
Zotero 插件